SUNITINIB MALATE (Sunitinib malate) Nursing Considerations

What is the generic name?

SUNITINIB MALATE

What is the Trade Name for SUNITINIB MALATE?

Sunitinib malate

What are the Indications for SUNITINIB MALATE?

• 1 INDICATIONS AND USAGE Sunitinib malate capsules are a kinase inhibitor indicated for: ‚Ä¢ treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate. (1.1) ‚Ä¢ treatment of adult patients with advanced renal cell carcinoma (RCC). (1.2) ‚Ä¢ adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy. (1.3) ‚Ä¢ treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease. (1.4) 1.1 Gastrointestinal Stromal Tumor Sunitinib malate capsules are indicated for the treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate. 1.2 Advanced Renal Cell Carcinoma Sunitinib malate capsules are indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC). 1.3 Adjuvant Treatment of Renal Cell Carcinoma Sunitinib malate capsules are indicated for the adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy. 1.4 Advanced Pancreatic Neuroendocrine Tumors Sunitinib malate capsules are indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease.

References: https://open.fda.gov/